WallStSmart

Ituran Location and Control Ltd (ITRN)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ituran Location and Control Ltd generates 39% more annual revenue ($359.02M vs $258.90M). ITRN leads profitability with a 16.2% profit margin vs -15.5%. ITRN earns a higher WallStSmart Score of 60/100 (C).

ITRN

Buy

60

out of 100

Grade: C

Growth: 6.0Profit: 8.5Value: 4.0Quality: 9.0
Piotroski: 6/9Altman Z: 4.08

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ITRNFair Value (-1.9%)

Margin of Safety

-1.9%

Fair Value

$46.59

Current Price

$57.60

$11.01 premium

UndervaluedFair: $46.59Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ITRN4 strengths · Avg: 9.3/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.0810/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
28.9%9/10

Every $100 of equity generates 29 in profit

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ITRN2 concerns · Avg: 2.5/10
Market CapQuality
$1.13B3/10

Smaller company, higher risk/reward

PEG RatioValuation
3.412/10

Expensive relative to growth rate

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ITRN

The strongest argument for ITRN centers on Debt/Equity, Altman Z-Score, Return on Equity. Profitability is solid with margins at 16.2% and operating margin at 21.8%. Revenue growth of 12.8% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ITRN

The primary concerns for ITRN are Market Cap, PEG Ratio.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ITRN profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ITRN scores higher overall (60/100 vs 41/100), backed by strong 16.2% margins and 12.8% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ituran Location and Control Ltd

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Ituran Location and Control Ltd., provides location-based services and wireless communication products. The company is headquartered in Azor, Israel.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?